Scienture Holdings, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-08-01.
Scienture Holdings, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on August 1, 2025. The filing reports $1.72M sold. Its industry group is Pharmaceuticals. It names Narasimhan Mani (Executive Officer, Director), Shankar Hariharan (Executive Officer, Director), Donald Fell (Director) (SEC Form D/A, August 1, 2025).
Is this your company?
Sell to companies like Scienture Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Scienture Holdings, Inc.
Free to see. No signup.
More on the people and the money behind Scienture Holdings, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Scienture Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Scienture Holdings, Inc. raises, hires or launches. No email unless you switch it on.
Watch Scienture Holdings, Inc. →Get the full cited report on Scienture Holdings, Inc.
What the filing shows about Scienture Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Scienture Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Scienture Holdings, Inc.'s address as 20 Austin Blvd., Commack, NY 11725.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-08-07: the amount sold changed from $1,300,000 to $1,715,000; the number of investors changed from 4 to 8; sales commissions changed from $0 to $35,000. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Scienture Holdings, Inc. See pricing
Scienture Holdings, Inc. is a registered filer with the SEC (CIK 1382574) and has filed since 2024-12-19. 3 filings are on record, the latest on 2025-08-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Scienture Holdings, Inc.'s Form D of 2025-08-01 names Narasimhan Mani, Shankar Hariharan, Donald Fell and 2 more as its officers, directors or promoters.
Its new offerings report $4.63M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Proceeds are to be used for general working capital purposes, which may include payment of ordinary courseremuneration to officers.
Checked away from the filing. What is below does not come from the record on sec.gov.
Scienture Holdings, Inc. (NASDAQ: SCNX) is a comprehensive health services and pharmaceutical company that delivers novel specialty products.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Narasimhan Mani is named as Executive Officer and Director on the Form D that Scienture Holdings, Inc. filed with the SEC on 1 August 2025, one of 5 people that filing names.
Shankar Hariharan is named as Executive Officer and Director on the Form D that Scienture Holdings, Inc. filed with the SEC on 1 August 2025, one of 5 people that filing names.
Donald Fell is named as Director on the Form D that Scienture Holdings, Inc. filed with the SEC on 1 August 2025, one of 5 people that filing names.
Mayur Doshi is named as Director on the Form D that Scienture Holdings, Inc. filed with the SEC on 1 August 2025, one of 5 people that filing names.
Subbarao Jayanthi is named as Director on the Form D that Scienture Holdings, Inc. filed with the SEC on 1 August 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-08-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Scienture Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Scienture Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Scienture Holdings, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Scienture Holdings, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Scienture Holdings, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (scientureholdings.com).
Each opens in a new tab, filled in for Scienture Holdings, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/scienture-holdings-inc-form-d-25000001